Abiopharma

Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Denton Sheila A. 🟡 adjusted position in 598 shares (1 derivative) of INCYTE CORP (INCY) at $84.97 Transaction Date: Sep 02, 2025 | Filing ID: 000004

AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE

New Form 8-K - Indaptus Therapeutics, Inc. Filed: 2025-09-04 AccNo: 0001493152-25-012630 Size: 238 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Equillium, Inc. Filed: 2025-09-04 AccNo: 0000950170-25-113023 Size: 155 KB Item 8.01: Other Events

Amneal Pharmaceuticals, Inc. - Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension

Indaptus Therapeutics Notification (INDP)

Reich Kristian 🟡 adjusted position in 49.0K shares (1 derivative) of MoonLake Immunotherapeutics (MLTX) Transaction Date: Sep 02, 2025 | Filing ID: 084492

Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise ofUnderwriters’ Option to Purchase Additional Shares

Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension

Praxis Precision Medicines to Participate in September Investor Conferences

Indaptus Therapeutics Provides Clinical Update

Inventiva annonce sa participation à plusieurs conférences investisseurs en septembre

Inventiva to Participate in Upcoming September Investor Conferences